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Executive summary 
Contagious bovine (CBPP) and caprine pleuropneumonia (CCPP) are OIE-listed diseases 
because of the socio-economic impact they have mainly on smaller holdings often on 
marginal land in Asia and Africa. Despite some successful attempts in Nigeria at controlling 
CBPP in the 1970s there is substantial evidence that the disease is endemic in many parts of 
the country. CCPP, on the other hand, has been suspected based on clinical and pathological 
signs but has not been confirmed by laboratory tests. Furthermore, there have been no 
surveys to show its distribution in the country.  Following the purchase of equipment, test 
kits and reagents and refurbishment and training, a mycoplasma laboratory was established 
and commissioned in July 2020 by the Vice Chancellor of the University of Ilorin, Kwara 
state, western Nigeria. A commercial competitive ELISA for the serological detection of the 
causative agent of CBPP, Mycoplasma mycoides subsp mycoides, was used to screen 
abattoirs in the state. Between 6 and 135 samples were taken from each; the percentage of 
positive sera varied between 0 and 13.5%. However, where more than 40 samples were 
taken seroprevalence was shown to be between approximately 7 and 14%.  Later, 10 cattle 
were chosen from each of four abattoirs with high seroprevalence for more detailed 
examination.  CBPP-positive cattle (4/10) were found at Ilorin East based on clinical, gross 
pathological, cultural and serological criterion.  M. m. mycoides was isolated and identified 
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using specific staining in diagnostic medium. Cattle from the other three abattoirs were 
clinically and pathologically negative but some were seropositive and yielded mycoplasmas 
but these were not considered specific for M m mycoides. Confirmation of the Identity of 
isolates is on-going using growth inhibition tests. In parallel, 10 goats were examined for 
CCPP at each of these abattoirs. Again, while confirmation is still being carried out on 
isolates, goats examined at two abattoirs were positive for CCPP based on clinical, 
pathological and laboratory tests. M. c. capripneumoniae was identified based on specific 
staining in diagnostic medium which represents the first isolation of M c. capripneumoniae 
in Nigeria. Culture-positive goats were also seropositive suggesting CCPP is widespread in 
Kwara state though number of goats examined was small.  A serological survey using the 
cELISA of over 300 goats kept extensively gave an average seroprevalence of 4.4%. Finally, 
the cELISA was used to identify various risk factors associated with CBPP infection in cattle 
herds in Kwara state. Herd size was the most significant factor with herds greater than 100 
more likely to have a higher percentage of positive cattle. Evidence was seen that some 
breeds, White Fulani and Adamwa Gudaly, were more susceptible to CBPP though not 
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• Establishment and commissioning of diagnostic testing for CCPP and CBPP by University of 
Ilorin 
• Identification of causative mycoplasmas of CBPP, Mycoplasma mycoides subsp. mycoides 
• First isolation and identification of causative agent of CCPP,  M. capricolum susbsp 
capripneumoniae, in Nigeria 
• Detection of other ruminant mycoplasmas 
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• Estimation of seroprevalence of CBPP and CCPP in Kwara state 
• Collaboration arranged with Lusaka, Zambia and OIE Reference Laboratory, Gaberone 
Botswana 
• Paper published on previous preliminary studies of CBPP/CCPP  
 
Introduction 
Contagious bovine (CBPP) and caprine pleuropneumonia (CCPP) are major pathogens of 
livestock and listed by the OIE for their socio-economic impact on farming communities. 
Control of CBPP in Nigeria was nearly achieved in the early 1980s but the disease re-
emerged a few years later probably from bordering countries of Niger, Chad and Cameroon 
(Nicholas et al, 2000). In spite of an eradication campaign launched in 1970, outbreaks rose 
rapidly from 1986 to a peak in 1989 when over 10,000 cattle were affected. Presently, the 
disease is widespread in Nigeria (table 1) and the recent wave of civil and religious unrest 
has enabled the spread of the causative agent, Mycoplasma mycoides subsp. mycoides, in 
the northern part of the country particularly Borno State making accurate monitoring 
difficult (Olorunshola et al 2017). 
 
Table 1: Officially confirmed CBPP Outbreak in Nigeria (2005-2015) 
 
Year Susceptible Cases Outbreaks Deaths Destroyed Slaughtered 
2005       207      22       2     2 0   0 
2006       231      65      2     9 0   0 
2007      365    707      7     6 0 10 
2008 46,919 1,703    28   69 0   0 
2009 24,049 1,223    39   72 0   7 
2010   9,586   194    17   13 0   7 
2011 11,771    316   17   59 7 23 
2012 15,345 1,389     6   23 0   0 
2013   2,488    158   10   68 0   2 
2014   7,500        8     1     1 0   1 
2015   7,500        8     1     1 0   1 
Total 125,961 5,786 130 323 7 51 
 
 
Our recent preliminary clinical and serological work using pen-side tests has shown that 
both CBPP and CCPP are probably present in livestock slaughtered at the abattoirs in Kwara 
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state (Olorunshola et al 2020). CCPP has been suspected based on clinical and pathological 
signs but has not been confirmed in Nigeria by laboratory methods. However, the causative 
agent M. capricolum subsp. capripneumoniae has been detected by cultural methods in 
neighbouring countries of Niger and Chad (Manso-Silvan and Thiaucourt 2019) so it is highly 
likely that there have been incursions of affected goats across borders into northern Nigeria 
and subsequently into other regions of the country. Furthermore, there have been no 
surveys to show its distribution in the country.  However, identification could be 
confounded by other respiratory diseases like other bovine and caprine mycoplasmoses so 
more specific confirmatory testing is required to enable more accurate diagnosis which will 





The main aim of this project is to set up a diagnostic laboratory for mycoplasma diseases 
with special reference to CBPP and CCPP at Ilorin University and to determine their 





1. Undergo mycoplasma training/discussions at APHA, Weybridge and Mycoplasma 
Experience Ltd, UK (commercial producers of specialist mycoplasma media and 
contract testers) 
2. Introduce serological testing by buying kits for CBPP and CCPP comprising 
commercially available latex agglutination (APHA, UK) and competitive ELISA tests 
(Idexx, France). 
3. Establish mycoplasma isolation methods by purchasing commercially available 
diagnostic medium (Mycoplasma Experience, UK) and to develop and compare 
home-made media. 
4. Obtain specific antisera for commonly occurring ruminant mycoplasmas to enable 
identification by growth inhibition tests.  
5. Initiate molecular identification of mycoplasmas by buying kits and collaborating 
with other African laboratories 
6. Prepare and test bank of serum and clinical samples from cattle and goats at local 
abattoirs particularly those showing signs of respiratory disease. 
7. Investigate reported outbreaks in the field when they occur 






Materials and Methods 
 
Study Area.   
 
Ilorin is the capital of Kwara state which lies on the plain in the southwest of Nigeria at 
Latitude 8o 30’ and 8o 50’ N and Longitude 4o 20’ and 4o35’ E. The city occupies an area of 
about 468 km2 situated within the forest and the guinea savannah regions of Nigeria. The 
Ilorin climate is tropical being influenced by the two prevailing trade winds and experiences 
an annual rainfall of between from 1000 and 1500mm with daily average temperatures of 
25oC, 27oC and 22.5oC in January, May and September respectively. The sampling locations 
for this study were four local government areas: Moro, Edu, Pategi and Burateen in Kwara 
state (Fig.1). 
 






A one-week training period was carried out at the OIE Reference Laboratory for Ruminant 
Mycoplasmas, APHA, UK covering mycoplasma culture, denaturing gradient gel 
electrophoresis procedure, Immunoblotting technique, PCR technique, ELISA, DNA 
extraction and lectures with laboratory experts and a consultant on quality control and 
standard operation procedures. Contacts were made to facilitate collaboration between 
APHA and Ilorin University during the project. A full report is attached [Appendix I]. 
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Discussions and advice were given at Mycoplasma Experience ltd UK , specialist media 
producers and contract researchers. Practical advice was provided and a tour of the facility 




Essential equipment and reagents were purchased and refurbishment of buildings carried 
out throughout the project to provide an appropriate environment for this specialized area 














(1) Latex agglutination tests which provide rapid serological diagnosis for both CBPP and 
CCPP were bought from APHA, UK. OIE approved competitive ELISA tests for CBPP 
and CCPP which provide a more specific and sensitive detection of antibodies were 









(2) While serological tests provide a rapid and sensitive assessment for the presence of 
antibodies in affected animals it is not possible to distinguish current infection with 
past exposure so alternative tests are required to look for active infection. 
Mycoplasma isolation is the gold standard method but can be confounded by 
mycoplasma fastidiousness and bacterial contamination of the samples. Initially 
specific media was purchased from Mycoplasma Experience UK Ltd which has the 
advantage of being quality controlled on low passaged isolates. In addition, while 
enabling good growth the media also contain a diagnostic property which enables 
identification of the target mycoplasmas: a red staining of the colonies indicates 
specific detection on isolated colonies.  To confirm these results the growth 
inhibition test using specific antisera bought from APHA. However, the media are 
expensive and unsustainable in the long term so home-made media was produced 
and compared with the commercial product in parallel. 
 







(3) Molecular tests such as PCR are standard techniques in reference laboratories and 
provide rapid and sensitive detection of specific nucleic acid sequences and 
overcome the problems of isolation and growth of mycoplasmas but these were 
beyond the scope of the present project. However, DNA isolations were carried out 
on a selection of samples and frozen for later in-house identification. In the 
meantime, some samples were sent to Dr G Muuka at the Central Veterinary 






Ad hoc investigations of suspected outbreaks 
 
Several field outbreaks suspected to be CBPP and CCPP were investigated 
 





Risk factors associated with CBPP 
 
While plans were being made to sample local abattoirs, serological testing by cELISA of 
stored and freshly collected sera from suspected herds in the state was carried out looking 
at various aspects of CBPP infection including: seasonality, prevalence in the local 








Four abattoirs were selected for sample collection for CBPP and CCPP in cattle and goats 
respectively. Sera, lung samples, pleural fluid if present was collected after examining the 
animals both clinically and pathologically. 
 
Serological survey for CCPP 
Goat herds comprising 320 animals in the 4 targeted LGAs were screened with the cELISA 




Establishment of mycoplasma laboratory 
 
Following purchasing of equipment and reagents, refurbishment of the building and training 
of staff the Mycoplasma Diagnostic and Research Laboratory was commissioned by the 
University Deputy Vice Chancellor Professor Mikhail Olayinka Buhari for the VC Prof 
Sulyman Age Abdulkareem on the 9th July 2020 in collaboration with the University of 














Ad hoc investigations of outbreaks 
 
Two nomadic herds in Ovo and Kwara states in the north of the country suspected of being 
naturally affected herds with CBPP were monitored with serological tests including the latex 
agglutination and cELISA and examined for specific clinical and pathological signs.  
 
The seroprevalence of CBPP in the 278 head of cattle in Ovo state was over 50% and 
contained 13% clinically sick cattle while the majority of the 460 cattle herd in Kwara state 
were morbid with over 66% being seropositive. While slightly less sensitive that the cELISA 
the LAT was robust and highly effective when used in the field.  
 
Risk factors factors included lack of vaccination, repeated contacts with other herds, lack of 
veterinary inspection and insufficient feed and water during the dry season. 
 
Long acting tetracyclines, tyrosine and vitamin B complex were applied to the Ovo herd 
with immediate beneficial results even in cattle overtly sick. In Kwara state cattle were 
vaccinated and treated with erythromycin and sulphimidine as recommended by sensitivity 














Screening of abattoirs in Kwara State for serological evidence of CBPP 
 
Table 2: ELISA testing to select abattoirs with most potential cases positives to 
CBPP 
LGA No of Cattle 
Sampled 
No Positive (%) OR (95% CI) p-value 
Ilorin West 119 10 (8.4) 0.59 (0.21 – 
1.65) 
0.40 
Patigi 15 0 (0.0) q 0.34 
Ifelodun 6 0 (0.0) q 1.00 
Ilorin East 228 19 (8.3) 0.58 (0.23 – 
1.47) 
0.29 
Ilorin South 52 7 (13.5)                                            1.00 
Offa 70 7 (10.0) 0.71 (0.23 – 
2.18) 
0.58 
Oyun 19 1 (5.3) 0.36 (0.04 – 
3.12) 
0.67 
Asa 28 1 (3.6) 0.24 (0.03 – 
2.04) 
0.25 
Moro 9 1 (11.1) 0.80 (0.09 – 
7.45) 
1.00 
Baruten 44 3 (6.8) 0.47 (0.11 – 
1.94) 
0.34 
Kaiama 48 4 (8.3) 0.58 (0.16 – 
2.14) 
0.53 
Total 638 53 (8.3)   
LGA: local government areas 
 
Results showed abattoirs in Ilorin west, Ilorin east, Ilorin south and Offa offered best 
and most convenient opportunity to obtain positive cases (table 2; fig. 8)). In 
addition, they are the most fully functioning abattoirs and accommodate a larger 
number of cattle which are brought daily but early attendance is necessary to obtain 









Ten cattle were examined for CBPP at 4 slaughterhouses, specifically for typical clinical signs 
and pathognomic lesions. Blood was taken for serology and lung sampled for culture. Four 
cattle at Ilorin East showed distinct lesions in the lung (Table 3; Fig 9a). Mycoplasmas were 
isolated from cattle at all abattoirs but only those at Ilorin East showed specific staining in 
the ME diagnostic medium (Fig. 10). Growth inhibition tests are being carried out to confirm 
identity. In addition isolates have been sent to the reference laboratory at Lusaka, Zambia 
for confirmation. All culture positive cattle were also serologically positive with both ELISA 
and LAT; however, a single animal was seropositive by LAT but negative by other tests 
suggesting this could have been a false positive.  Other mycoplasmas isolated may have 
been commensals like M bovirhinis or pathogens like M bovis; indeed lung lesions in one 
cow at Ilorin South were very similar to those reported for M bovis (fig.9b). Confirmation is 
being sought.  
 












Fig 9 (a) Cattle lungs showing fibrin deposition;  (b) areas of focal necrosis in the lung 
(arrowed); (c) pleural fluid in thoracic cavity; (d) sequestrum 
 
  
(a)         (b) 
 







Table 3: Results summary of cattle pm at 4 abattoirs for CBPP. Abattoir highlighted 




Culture        ELISA             LAT 
Ilorin South 0 3* 1 0 
Ilorin West 0 4*  0 0 
Ilorin East 4 3ǂ 3 4 
Offa 0 3* 0 1 
 4 13 4 5 
 
* colonies may be commensals like M bovirhinis etc 
ǂ some colonies showing distinct staining for M. m. mycoides with ME diagnostic medium 
  
 







Ten goats were examined for CCPP at 4 slaughterhouses, specifically for typical clinical signs 
and pathnognomic lesions (table 4). Blood was taken for serology and lung sampled for 
culture. Goats at 2 abattoirs (West and East) showed lesions suggestive of CCPP (fig. 10) 
which was confirmed serologically (fig.11). Mycoplasmas were isolated and identified as M 
c. capripneumoniae based on specific staining in ME diagnostic medium (Fig. 12). Further 
confirmation is being sought as for those from cattle. Other mycoplasmas isolated but not 
staining may have been M ovipneumoniae (fig. 13) or M arginini, both of which have been 
linked to disease in small ruminant. Confirmation is also being sought. Generally, the LAT 
gave more positive reactions than the cELISA but may have included some false positives 
due to cross reaction with other members of the M mycoides cluster such as M.m capri 
which has a worldwide distribution. The cELISA is more specific and detected those goats 












Fig. 10. Goat lungs showing severe congestion (a), fibrin deposition (b) and pleural fluid 















Table 4:  Results summary of goat pms at 4 abattoirs for CCPP. Those highlighted 




Culture        ELISA             LAT 
Ilorin South 0 4* 0 2 
Ilorin West 4 5ǂ 2 6 
Ilorin East 4 3ǂ 3 4 
Offa 0 3* 0 1 
 8 15 5 13 
 
*may be M arginini or M ovipneumoniae with centreless colonies 







































Risk factors associated with CBPP infection 
 
(i) It has previously been observed and reported in our previous study that more 
females are reared and hence more cows are slaughtered daily. Here we confirm 
these findings that females are more susceptible to CBPP though not significantly 
(table 5) 
 
Table 5: ELISA testing of male and female cattle 







Male 139 9 (6.5)   1 
Female 499 44 (8.8) 1.40 (0.66 
– 2.94) 
0.49 
Total 638 53 (8.3)   
 
 
(ii) From table 6 it is apparent that more seropositives were found during the rainy 
season than in the dry season but not significantly 
 Table 6: Effect of season on detection of seropositives for CBPP 
Season No of Cattle 
Sampled  
No Positive (%) OR (95% CI) p-value 
Dry 244 19 (7.8)               1 
Rain  394 34 (8.6) 1.12 (0.62- 
2.01) 
0.77 






(iii) Different breeds of cattle were tested for CBPP. Red Bororo, White Fulani and 
Adamawa Gudali breeds showed highest percentage of seroprevalence (table 7)  
 
Table 7: Percentage of seropositivty in different breeds of cattle 
 




OR (95% CI) p-value 
White Fulani breed 347 32 (9.2)   1 
Adamawa Gudali breed 114 10 (8.8) 0.95 (0.45 – 
1.99) 
1.00 
Sokoto Gudali breed 51 4 (7.8) 0.83 (0.28- 
2.48) 
1.00 
Bokolo 45 3 (6.7) 0.70 (0.21 – 
2.40) 
0.78 




Gudali cross   
25 1 (4.0) 0.41 (0.05 – 
3.13) 
0.71 
White Fulani/Sokoto Gudali 
cross   





9 0 (0.0) q 1.00 
Azawak breed 3 0 (0.0) q 1.00 
Friesian cross breed 5 0 (0.0) q 1.00 
Total 638 53 (8.3)   
 
 
(iv) Slightly higher seroprevalence of CBPP was seen targeting the abattoir rather 
than farm settlements (Table 8) 
 
Table 8: Comparison of CBPP seroprevalence at different locations 
 
Location No of Cattle 
Sampled 
No Positive (%) OR (95% CI) p-value 





300 22 (7.3)                        1 
Total 638 53 (8.3)   






(v) Results show the larger the herd the higher the seroprevalence (Table 9) which is 
in line with studies of M bovis and probably indicates greater movement of cattle 
into the herd (Nicholas et al 2016) 
 
Table 9: Cattle Herd Size for Farm Settlement  
 




OR (95% CI) p-value 
1 - 25 6 0 (0.0) q 1.00 
26 - 50 62 4 (6.5) 1 
51 - 75 169 11 (6.5) 1.01 (0.31 – 
3.30) 
1.00 
76 - 100 44 4 (9.1) 1.45 (0.34 – 
6.14) 
0.72 







Serological survey for CCPP 
Goat herds comprising 160 animals in each of the 4 targeted LGAs were screened with the 
cELISA for specific antibodies to CCPP. Results of the serological screening of goat herds are 
shown in table 10. In general, seroprevalence was low varying roughly between 1.3 and 
7.5% averaging about 4.4% for the state. 
 
Table 10: Summary of the CCPP Screening 
 
LGA Species  Total sample  ELISA Results 
No positive  % positive  
South Caprine 80 1 1.3 
West Caprine 80 3 3.8 
East Caprine 80 6 7.5 
Offa Caprine 80 4 7 









Results obtained in this study confirmed the presence of M m mycoides, causative agent of 
CBPP, and showed for the first time the isolation and detection of M c capripneumoniae, the 
causative agent of CCPP, which has long been suspected based on clinical and serological 
evidence.  The use of commercial media and diagnostic tests is probably not sustainable for 
the mycoplasma laboratory at Ilorin University once funding stops although the University 
has promised to support the laboratory where it can. However, during the course of the 
study, successful attempts have been made to produce media for mycoplasma isolation. 
Preliminary studies have shown that while M m mycoides grows well, the more fastidious M 
c capripneumoniae requires improvements to medium formulation. It may also be possible 
now to produce antigens in vitro which can be used for in-house diagnostic tests such an 
indirect ELISA and LAT. 
 
Both diseases appear widespread in Kwara state and probably throughout Nigeria.  In this 
report a widespread serological survey of 320 commercial goats in the LGAs for CCPP was 
carried out and showed an approximate seroprevalence of 4.4%. This was lower than the 
results from a previous study of over 300 small ruminants in Northern Nigeria, (Olorunshola 
et al, 2020) which used the less specific latex test and could have been cross reacting with a 
M. mycoides cluster member such as M m capri which is widely prevalent. CCPP had a 
seroprevalence rate in affected herd of about 33% of which about 16% were showing 
clinical signs.  Using the more specific cELISA in our abattoir survey seroprevalence was 
approximately 12.5% although numbers of animals was much smaller. This still represent a 
significant level suggesting that CCPP is endemic in parts of Nigeria. Slaughter of these sorts 
of numbers of herds to control CCPP is clearly prohibitory to owners and authorities who 
may have to compensate. While antibiotics in particular oxytetracycline and some of the 
fluoroquinolones are effective against the mycoplasma (Ozdemir et al, 2006) this is an 
expensive and non- sustainable option for poor farmers and of course can lead to 
antimicrobial resistance.  Commercial vaccines are available against CCPP and have been 
shown to be protective but are of variable quality (Nicholas and Churchward, 2012). Isolates 
obtained in this study should be compared with those from other countries to see if any 
genetic or immunological differences would preclude the use of these commercial vaccines. 
In the short-term autogenous vaccines could be produced to see if inactivated Nigerian 
strains protect herds on a small scale. Larger scale trials could then be planned to compare 
with commercial CCPP vaccines produced elsewhere. 
 
CBPP remains a major problem in Nigeria. In this study seroprevalence was estimated 
between 8% in a population of over 600 cattle to 10% in our small abattoir survey. It is clear 
the disease is endemic in many parts of the country and even if successful control was again 
possible, incursion from infected neighbouring countries would be a continuous problem. So 
improved border controls are essential but more importantly widespread vaccination 
aiming to cover at least 80% of the national herd is paramount. This level was achieved 40-
50 years ago but the country today is struggling to achieve 20% which is far too small to 
enable control (Olorunshola et al, 2017). Numerous vaccines have been developed over the 
last 20-30 years but none have achieved the efficacy of the live T1/44 vaccine which is OIE 
approved and widely available in Africa. Increased coverage is presently the only solution 
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with perhaps the use of antibiotics in a targeted manner on herds experiencing severe 
outbreaks with ring vaccination carried out on adjacent herds. 
 
The newly commissioned mycoplasma laboratory at Ilorin University could play a crucial role 
in the control of both these diseases in Nigeria as it now has the capacity for both diagnosis 
and research with enthusiastic and talented leadership but requires both university and 
government help to sustain its efforts. Formal links with the OIE reference laboratory for 
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Establishment of diagnostic laboratory for mycoplasma diseases of livestock at Ilorin 
University with particular reference to CBPP and CCPP 
 
General 
At the end of this project, Ilorin university will have a functioning mycoplasma laboratory 
capable of diagnosing mycoplasma infections of livestock in particular the OIE listed 
diseases CBPP and CCPP, but it should be possible to gain some intelligence on other 
important diseases such as those caused by Mycoplasma bovis which is impacting on all 
cattle rearing countries.  It should also be able to diagnose other OIE diseases causing CA 
and avian mycoplasmoses 
 
Molecular tests 
While some limited identification of mycoplasmas is possible with the help of other 
laboratories, it will be necessary to bring this in house with the introduction of PCRs for the 
rapid identification of key pathogens. The establishment of 3-4 PCRs should be sufficient.  
With these we can detect most 4 small ruminant pathogens including contagious agalactia 
pathogens. CBPP and M bovis Isolates obtained in these studies could also be sent to 
collaborating labs to see how they compare with other isolates on the continent which may 
provide information on disease spread 
 
CBPP 
Information on the prevalence of CBPP in the state will be known as well as some additional 
information on breed and age susceptibility, seasonal factors, disease location etc for CBPP. 
Some knowledge of present vaccination coverage and cattle movements into the area will 
be valuable to assess control options. However, to improve the influence of the laboratory 
in the region, it will be necessary to get assistance from OIE laboratories in Africa. Contacts 
have been made with the lab at Gaborone who are willing to help with identification and 
other lab activities. I recommend sending Isaac there 
 
CCPP 
There are few confirmed reports of the presence of CCPP in Nigeria and we hope to add firm 
identification to our serological detection by the end of the project. Estimate of prevalence 
will also guide possible control measures. Commercial vaccines are available but efficacy is 
variable. They are not presently used in Nigeria because of the lack of awareness of this 
disease. Vaccine trials either experimental or on farm could be carried out. If successful data 
will be published then authorities contacted to recommend widespread vaccination rather 
than the present use of antimicrobials which can lead to resistance. MIC tests on isolates 






Report of the Training on establishing a diagnostic laboratory for CBPP and CCPP research 
project in Nigeria  
October 14th -18th, 2019  
 
Animal and Plant Health Agency, Addlestone, Weybridge, Surrey, UK 
 
Department of Bacteriology: 
 
Mycoplasma Group  
Training overview 
The Animal and Plant Health Agency, formerly Veterinary Laboratory Agency is the UK 
reference laboratory and research institution delegated for the purposes of diagnosis, 
research and production of vaccines and other biological for animal and plant health. This is 
also translated into investigating various pathogens and the production of diagnostic kits for 
the control of disease caused by mollicutes. The goal of this training was for Dr Isaac 
Olorunshola to acquire some hands on knowledge and skills in the primary isolation of 
mycoplasmas in ruminants as well as getting familiar with the materials and methods in 
culture, serology and molecular techniques used in the detection of animal mycoplasmas 
using modern technology.  
Training content 
• Registration and security checks at the main gate   
• Introduction to the facilities, health and safety procedures 
• Specific hand on observation on the following techniques  
I. Primary isolation of mycoplasmas by culture:  
I observed and participated in the documentation and processing of lung samples 
submitted from the field with the history of various species of animals suffering from 
diseases caused by mycoplasmas. Including Poultry, small ruminants, cattle, and 
others as differentiated and capped with red, white, blue and green covered bijou 
bottles respectively. Processing was carried out in a sterile biosafety cabinet. 
Incubation was done using a humidified incubator at 37 degrees with 5% CO2 for 21 
days i.e. 15 working days but growing samples are examined daily for growth or 
changes involving colour, consistency, turbidity, contamination, all these are 
recorded and actions taken, like filtration if broth culture are contaminated, sub 
culturing into fresh broth and sometimes old cultures or irreparable contaminated 
cultures are discarded. On two occasion’s pure broth growth were cultured into 
PPLO Agar to grow colonies of Mycoplasma bovis for me to view using the 
stereomicroscope-this I observed with pictures of the fried egg colonies taken. Other 
identification markers are presence of  
non-transparent film on top of the mycoplasma bovis broth culture while growing 
compared with a clean and transparent control broth. Other Mycoplasma species on 
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broth culture also show a characteristic swirl appearance when shaken first a sort of 
tornado wind cloud would emerge as opposed to a negative control broth. 
II. Other procedures I observed includes: 
1. DGGE procedure-Denaturing Gradient Gel Electrophoresis  
2. Immunoblotting technique 
3. PCR technique 
4. ELISA 
5. DNA extraction  
6. Hours of lectures with laboratory experts and a consultant on quality control and 




The summary of the week-long training programme is as displayed in the Table  
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I want to specially thank my sponsor, the Supporting Evidence Based Interventions 
programme (SEBI) of the University of Edinburgh for making it possible for me to undergo 
this training. To my Consultant and Mentor Dr Robin Nicholas for linking me with APHA the 
venue of this training. This has enabled me to observe many modern diagnostic techniques 
gathered more information on various potential mycoplasmas species for research 
endeavours, I have also expanded my contacts with more experts in this field. Above all the 
trainng has exposed me to the best practice and quality standards that would make my 
laboratory and research outputs acceptable internationally following the guides as 
contained in the ISO and OIE manuals. Finally, I wish to express my profound gratitude to 
you all, for your care, technical supports to have put me through all your facilities and 
procedures in spite of your tight schedule am indeed very grateful. There is no amount of 
words I can offer to commensurate with your kind gesture -I pray that God will continue to 
enlarge your coast as individual and as a Team. I enjoyed learning from you: Anne, Alannah, 
Owen, Jane, Georgia, Hilary, Serena, and last but not the least Graeme, as well as my 












Mycoplasma Experience Visit:  The Report 
Date =29/10/2019 
Venue = Mycoplasma Experience Complex-Redhill –South London 
Session A 
Discussions on: 
Media varieties for CBPP and CCPP, ordering, handling, preservation, transportation, and 
shelf life. Period of production and validation are critical period of 3 weeks to consider 
before delivery for use. Helena raised concerns about countries position on importation that 
I need to clarify shipment permit/license and custom position in Nigeria-paper work on 
shipment –through courier service providers such as FedEx, DHL, UPS, etc. 
Session B 
Tour of the laboratory facilities: Such as locations or rooms designated for Cultural isolation 
efforts, PCR and other molecular assays, isolated rooms for DNA extraction and 
preservation. Microscopy area for viewing isolates and photography and projections of 
colonies for proper identification and characterisation. Unit for handling live organisms and 
strict precautions to prevent cross contamination. I had the opportunity of seeing specialist 
equipment, materials and consumables for the purposes of media preparation, isolation, 
storage and preservation of isolates, DNA extraction equipment and kits as well as PCR unit 
comprising of processing unit-including, loading of DNA/samples, primers, premix and 
master mixing  as well as the computer based interpretations of PCR amplicons.  
Session C 
Launch break and further discussion: Dave and Helena shared their laboratory experiences 
with me and responded professionally to all my technical questions on mycoplasma media 
preparations, isolation and identification techniques. In all, I took note of some vital 
materials, media, and equipment that I will require and suggested those to Robin-who also 
witnessed every sessions of this visit. Helena made the photocopies of their media price list 
for me together with the instructions on how the media could be handled and utilized 
fruitfully. Both Dave and Helena assured me of their readiness and willingness to address 
and respond to any challenges that I may be confronted with when am back at work in my 





Appendix III:  
 
Expenditure: equipment, refurbishment and regents purchased during project 
 
Equipment/ Reagents 
ELISA Reader, Kits and Printer 
Deep freezer 
Standing freezer and fridge 
Minor laboratory equipment 
Mycoplasma Experience media (2 consignments) 
ANTISERA, BIOVILAT AND CAPRILAT reagents from APHA-UK 
Avian mycoplasma antigens from Turkey -Free 
Routine Laboratory wares and culturing consumables 
DNA extraction kits and consumables 
Primers for PCR and sequencing 
Stereomicroscope and camera 
Portable lyophilizer 
Single and multi-channelled pipepettes 
Laboratory refurbishment 
Equipment/ Reagents 
ELISA Reader, Kits and Printer 
Staff costs 
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